NEW YORK, Sept. 15, 2017 -- Stull, Stull & Brody today announced that a complaint has been filed on behalf of the 401(k) defined contribution plan of Chicago Bridge & Iron Company N.V. ("CBI" or the "Company") (NYSE:CBI). Among other things, the complaint alleges that fiduciaries of CBI's 401(k) plan violated the Employee Retirement Income Security Act of 1974 ("ERISA") by offering CBI stock as an investment option under the plan when it was not prudent to do so and by failing to disclose the Company's true financial and operating condition to participants and beneficiaries of the plan.
If you held CBI stock in an individual account under a Company 401(k) plan during 2013 and 2014 and you have questions about your legal rights or interests with respect to these matters, please contact Michael Klein, Esq. at Stull, Stull & Brody by e-mail at [email protected], by calling 212-687-7230 x147, by fax to 1-212-490-2022, or by writing to Stull, Stull & Brody, 6 East 45th Street, New York, NY 10017. You can also visit our website at www.ssbny.com.
The action filed in the U.S. District Court for the Southern District of New York focuses on whether, since October 29, 2013, the defendants failed to protect the CBI 401(k) Plan from artificial inflation in CBI’s common stock resulting from hundreds of millions of dollars in liability and had improperly accounted for CBI’s goodwill during 2013 to cover losses associated with delays and overruns on the Nuclear Projects. As a result, CBI stock allegedly traded at artificially exaggerated prices of over $87/share during the Class Period, before dropping to under $40/share in late 2014.
You may retain Stull, Stull & Brody, or other counsel of your choice, to represent you. Stull, Stull & Brody has litigated many class actions for violations of ERISA and securities laws in federal courts over the past 40 years and has obtained court approval of substantial settlements on numerous occasions. Stull, Stull & Brody maintains offices in New York and Beverly Hills.
Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome.


OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO 



